Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies
Clinical trial NCT01204164 · COMPLETED
Trial details
- NCT number
- NCT01204164
- Sponsor
- Tragara Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2016-03-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.